James Joaquin

Background

James Joaquin is Co-Founder and Managing Director of Obvious Ventures, the San Francisco-based impact venture firm he co-founded in 2014 alongside Ev Williams (co-founder of Twitter and Medium) and Vishal Vasishth ¹. He describes himself as a “seven-time CEO” and serial entrepreneur who transitioned into venture capital in 2007 ².

Joaquin grew up in a Portuguese fishing community in southeastern Massachusetts and studied computer science at Brown University, where he co-founded Clearview Software, which was subsequently acquired by Apple ³. He spent six years at Apple in engineering and marketing roles, working on the Newton product line ⁴. He then co-founded When.com, an Internet calendar and events service that was acquired by AOL ³. After the AOL acquisition, he became President and CEO of Ofoto, leading the online photo service from its early days through its acquisition by Kodak, where he grew it into the world’s largest online photo service ³. He next served as President and CEO of Xoom Corporation (2005–2006), a digital money transfer platform that went public in March 2013 and was subsequently acquired by PayPal in 2015 for approximately $890 million ³⁴. He also served as President and CEO of Xmarks/Foxmarks (2008–2010), a bookmark-syncing service that was acquired by LastPass ⁴.

Before co-founding Obvious Ventures, Joaquin held two VC roles: Venture Partner at Bridgescale Partners (2007–2008), where he led investments including Snapvine, IMVU, and Plum Organics ⁴⁵; and Partner at Catamount Ventures (2011–2014), where he led consumer internet and consumer packaged goods investments including the Nest Collective (later Plum Organics) ⁵⁶. He also served as an advisor and board member at Kapor Capital during this period ⁶.

In 2014, Joaquin co-founded Obvious Ventures with the conviction that the most valuable companies of their time would be those solving humanity’s biggest problems ¹. The firm has now raised five funds totaling over $1.3 billion in AUM: Fund I ($123M, 2014), Fund II ($192M, 2017), Fund III ($272M, 2020), Fund IV ($355M, 2022), and Fund V ($360,360,360, closed January 2026) ⁷⁸. The Fund V amount reflects what Joaquin described as a “360-degree view” across the firm’s three pillars ⁹.

At Obvious, Joaquin has personally led investments in Diamond Foundry, Beyond Meat, Incredible Health, Dexterity, and Obello, among others ¹²¹⁰. He sits on the boards of portfolio companies including Incredible Health, Beam, Enervee, Bakpax, Torch, and Taika ¹¹. He was a featured speaker at TEDAI San Francisco in October 2025, presenting on responsible AI applications in trillion-dollar industries ¹².

Stated Thesis

Joaquin’s stated investment thesis centers on what he terms “world positive” venture capital: backing founders whose core products inherently create positive environmental or social outcomes while generating substantial financial returns ¹¹³. He co-authored and pioneered the World Positive Term Sheet (2017) and the ESG Term Sheet (2022) to embed mission-driven governance into Obvious’s standard deal terms ¹³¹⁴.

He articulates the firm’s investment framework as a “time machine”: identifying a researched point of view on where the world is heading, and backing exceptional founders bringing exponential technologies to market in the near future ¹⁵. The firm invests within specific thematic categories—food, transportation, healthcare, and other fundamental building blocks of society ¹⁵.

Joaquin has described his focus areas as: sustainability, health, wellness, consumer packaged goods, fintech, and computational biology, while explicitly avoiding enterprise SaaS, ad tech, and cybersecurity ⁴. His most recent public thesis centers on “generative science”—large AI models trained on chemistry, physics, and biology that can generate scientific breakthroughs in decarbonization, biotech, materials science, and robotics—as distinct from the productivity-focused large language model wave ¹⁶.

The firm’s current Fund V strategy targets approximately 10 investments per year at seed and Series A, with check sizes of $5M to $12M ⁹.

Inferred Thesis

Basis: 30 verified investments drawn from the Obvious Ventures portfolio page, TechCrunch, ImpactAlpha, and firm blog posts. Obvious Ventures has disclosed approximately 100+ portfolio companies across five funds; this represents roughly 25–30% of the total portfolio. Sample size is insufficient for precise percentages across all funds but is large enough to identify directional patterns.

Pillar distribution (30 verified investments): - Human Health / Healthtech: 12 investments (40%) — Incredible Health, Beyond Meat, Devoted Health, Virta Health, Galileo Health, Recursion Pharmaceuticals, Dyno Therapeutics, Inceptive, Gandeeva Therapeutics, Brightside Health, CareZone, Beam - Planetary Health / Climate: 11 investments (37%) — Diamond Foundry, Planet Labs, Proterra, Pyka, Enervee, Zanskar, Aifleet, Forum Mobility, Canvas, Amply Energy, Mosaic - Economic Health / Fintech / Future of Work: 7 investments (23%) — Gusto, Dexterity, Incredible Health (dual-pillar), Baton, Obello, Corvus, Brightside Health

Stage distribution: The firm predominantly enters at seed and Series A, often leading rounds. Obvious led Incredible Health’s seed (2017), the Pyka Series B (2024), and participated in Beyond Meat’s Series D (2014) and Recursion’s Series A (2016). For Joaquin personally, board seat data confirms seed/early-stage entry as the primary strategy.

Sector patterns: Joaquin’s personally attributed investments cluster in three areas: (1) food systems / alternative protein, (2) labor market platforms in health and skilled work, and (3) advanced materials and AI-driven science. Within Obvious’s portfolio overall, the healthcare focus is the firm’s densest category and includes repeated thematic bets (diabetes care → Medicare advantage → primary care → AI drug discovery). The “flywheel” approach — Virta Health (OV1) → Devoted Health (OV2) → Galileo Health (OV3) — reflects deliberate sector expertise compounding across funds ¹⁷.

Founder profile patterns: Based on portfolio data, Obvious (and Joaquin specifically) shows a clear preference for mission-driven founders with strong operating backgrounds. Iman Abuzeid (Incredible Health) is a physician-entrepreneur; founders of Recursion, Inceptive, and Gandeeva have deep scientific PhDs. The firm’s ESG term sheet process involves requiring founders to articulate their company values before the check clears ¹⁴.

Geographic focus: Predominantly US-based companies, with a concentration in San Francisco Bay Area, though portfolio includes companies from across North America.

Co-investor patterns: Frequent co-investors in Obvious portfolio companies include Andreessen Horowitz, General Catalyst, Prelude Ventures, Google Ventures, Khosla Ventures, and NFX. Pyka’s Series B (led by Obvious) included Prelude Ventures, Piva Capital, and Catapult Ventures ¹⁸.

Notable divergence from stated thesis: While the firm emphasizes equal weight across three pillars, the verified portfolio skews toward Human Health (40%), suggesting a stronger practical concentration there. Also notable: Obvious participated in Beyond Meat’s Series D (a growth-stage round), suggesting willingness to invest later in high-conviction category bets, contrary to a strict seed/Series A mandate.

Portfolio

The following table represents verified investments attributed to Obvious Ventures, focused on deals in which James Joaquin has been identified as the lead partner or board member. The full firm portfolio exceeds 100 companies.

Note: Years marked ~2015 or ~2016 are estimates based on fund timing (OV1 was raised in 2014–2015) and secondary source descriptions. All entries are confirmed as Obvious Ventures investments; exact round dates could not be independently verified for all entries from available sources.

In Their Own Words

On Obvious Ventures’ founding thesis (from “How to Build a Time Machine,” obvious.com, December 7, 2021):

“At Obvious Ventures, we build time machines. Not the science fiction kind that teleport into the far future or the deep past. I’m talking about building a researched point of view on where the world is heading, and backing exceptional founders bringing exponential technologies to market in the near future.” ¹⁵

“The most successful founders are often ridiculed, derided, and overlooked early on.” ¹⁵

“Obvious is a thematic venture firm, investing within categories like food, transportation, healthcare, and other fundamental building blocks of society.” ¹⁵

On generative science (“Generative Science: Our Contrarian View of AI,” obvious.com, May 8, 2024):

“We believe generative science will emerge as humanity’s greatest invention, because it is, for the first time, an invention that can invent.” ¹⁶

“These systems will detect patterns, anomalies, and correlations in data that human researchers might otherwise never discover.” ¹⁶

“The systems behind AI-powered science must be explainable and transparent to build trust in how systems process complex data to arrive at complex conclusions.” ¹⁶

On the food system (“The Five Forces of Food,” obvious.com, September 17, 2018):

“We’re believers that these five forces are transforming the global food industry.” ³⁰

On fund five (“We made it to fund five,” ImpactAlpha, 2026):

“We made it to fund five, which is actually a big deal in the venture landscape.” ⁹

Ev Williams on founding Obvious (reported in multiple sources):

“We should invest in companies we wish existed in the world.” — Ev Williams, co-founder of Obvious Ventures, in the firm’s first year ⁷

What Founders Say

Iman Abuzeid, Co-Founder & CEO of Incredible Health, on James Joaquin’s pre-investment process (Obvious Ventures blog, “Incredible. Immigrant. Inspiring. Introducing Iman Abuzeid,” November 27, 2018):

“Before the money was in the bank, James asked us to write down our values. I thought it was going to be a trivial exercise, but it turned out to be one of the most meaningful things we’ve ever done.” ²³

She continued, regarding the company values that emerged from that exercise:

“They are the operating system of the company. They help set expectations and clearly communicate how we work together to achieve our mission.” ²³

On Obvious Ventures’ ESG term sheet process (from the ESG Term Sheet article, obvious.com, August 24, 2022, quoting Dr. Iman Abuzeid):

“Before the money was in the bank, James asked us to write down our values. I thought it was going to be a trivial exercise, but it turned out to be one of the most meaningful things we’ve ever done.” ¹⁴

No additional independently sourced founder testimonials about James Joaquin specifically were found beyond the Iman Abuzeid quotes above.

Connections

Board seats (verified): - Board Member, Incredible Health ¹¹ - Board Member, Beam (employee benefits) ¹¹ - Board Member, Enervee ¹¹ - Board Member, Bakpax ¹¹ - Board Member, Torch ¹¹ - Board Member, Taika ¹¹ - Board Observer, VSCO ¹¹

Prior employers (verified): - President & CEO, Xoom Corporation (2005–2006, then through IPO 2013 as he helped lead post-role) ³⁴ - President & CEO, Ofoto / Kodak Gallery (1999–2004) ³ - Co-Founder, When.com / AOL (1998–1999) ³ - Engineering & Marketing, Apple — Newton division (1989–1995) ⁴

Pre-Obvious VC roles: - Partner, Catamount Ventures (2011–2014) ⁶ - Venture Partner, Bridgescale Partners (2007–2008) ⁴⁵ - Advisor, Kapor Capital ⁶

Co-investors at Obvious (recurring): - Andreessen Horowitz (co-investor in Incredible Health) - NFX / James Currier (Incredible Health seed) - Prelude Ventures (Pyka Series B) - General Catalyst (Devoted Health)

Conference appearances: - Speaker, TEDAI San Francisco 2025 (October 21–22, 2025) ¹² - Speaker, Stanford Entrepreneurial Thought Leaders, November 17, 2021 ³¹

Sources